With that high profile introduction to investors Andy could have secured legitimate financing for a piece of future profits. If he also would have added experienced professionals to guide him through gov. rules and requirements we would have never reached such depths and very well may already hold a secure spot in the market. He has run his streak to 56 losing quarters (14 years). Nine years of them coming after the WSJ award. I am all in on this stock and hope it succeeds and the situation is certainly much improved. It still doesn't mean I have to stick my head in the sand and pretend years of missed opportunities and self serving financial gymnastics was somehow ingenious strategic planning. Now let me take cover. The poisoned arrows are sure to come.
What’s the conclusion? For me, it once again highlights Andy’s missteps. For a company to have a breakthrough product accompanied by media recognition 10 years ago and the only major market they have traction in is the U.K. doesn’t reflect well on management.
Indeed, if you look at 2014-16 financials sales were broken down by geography, and the major reason for the fall in overall sales was due to poor performance in Asia and Middle East.
There was much to be proud back in 2009 with this distinguished award given to Biel on product innovation by Wall Street Journal. In great company if you look at the guest speaker was ( Mark Benioff of Salesforce) whose company is impressive on all levels.
I have been here since 2009 - I know what I own, use the product for my back and shoulder successfully, and believe that better days, weeks, months and years ahead for this company. Own it not trade it!
BioElectronics Wins Wall Street Journal 2009 Innovation Award
FREDERICK, MD -- (Marketwire) -- 09/14/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.
Richard Staelin, Chairman of the Board of BioElectronics, said, "We are gratified that such a prestigious organization has validated the work of BioElectronics management to bring our innovative technology to market.
For a start-up of our size, it is exciting to be on a winners list that includes this year established technology leaders like Abbot Labs, HP, Qualcomm, National Semiconductor, Intel and NASA. The Wall Street Journal said that they received almost 500 nominations from around the world and selected only 36 winners." A complete file of this year's winners is available on the WSJ Online website or on http://www.healfasttherapy.com/wsjinnovationaward.
Andrew Whelan, BioElectronics CEO, will accept the award at The Wall Street Journal's 2009 Technology Innovation Awards ceremony on Oct. 13 at a dinner in Redwood City, Calif. featuring a keynote address by Marc Benioff, chairman and chief executive of Salesforce.com Inc. The ceremony will be held in conjunction with the Dow Jones VentureWire Technology Showcase.
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com ) and the Allay(TM) family (www.AllayPatch.com) of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
Market Data 
Markets 
AI
